Medicure, Inc. (NASDAQ:MCUJF)

PRESS RELEASE

published on 10/25/2024 at 00:00, 1 year 8 months ago

Medicure Announces Positive Settlement of Product Development and Supply Contracts
Medicure Inc. settles a product development and supply contract with a third party, receiving €1.5 million. Details remain confidential. Company focuses on pharmaceuticals and healthcare products in the U.S. market

Pharmaceuticals Medicure Inc. Product Development Healthcare Products Supply Contract
BRIEF

published on 08/14/2024 at 23:35, 1 year 10 months ago

Medicure finalise l'acquisition de la propriété intellectuelle de CanAm Bioresearch

Propriété Intellectuelle Acquisition De MediCure Recherche Biologique CanAm Développement Thérapeutique Actifs Pharmaceutiques
BRIEF

published on 08/14/2024 at 23:35, 1 year 10 months ago

Medicure Completes Acquisition of Intellectual Property from CanAm Bioresearch

Intellectual Property CanAm Bioresearch Medicure Acquisition Therapeutic Development Pharmaceutical Assets
PRESS RELEASE

published on 08/14/2024 at 23:30, 1 year 10 months ago

Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property
Medicure Inc. acquires intellectual property assets of CanAm Bioresearch Inc. related to new chemical entities for therapeutic use. Agreement terms and related party transaction details provided

Medicure Inc. New Chemical Entities Therapeutic Use CanAm Bioresearch Inc. Intellectual Property Assets
BRIEF

published on 08/14/2024 at 23:05, 1 year 10 months ago

Medicure publie ses résultats financiers pour le trimestre clos le 30 juin 2024

Résultats Financiers Medicure AGGRASTAT ZYPITAMAG Drogue Marley
BRIEF

published on 08/14/2024 at 23:05, 1 year 10 months ago

Medicure Reports Financial Results for Quarter Ended June 30, 2024

Financial Results Marley Drug Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE

published on 08/14/2024 at 23:00, 1 year 10 months ago

Medicure Reports Financial Results for Quarter Ended June 30, 2024
Medicure Inc. reports Q2 2024 financial results: net revenue down, EBITDA negative, net loss recorded. AGGRASTAT and ZYPITAMAG sales impacted. Analyst call on Aug 15, 2024

Financial Results EBITDA Medicure Inc. Net Loss Q2 2024
BRIEF

published on 06/24/2024 at 23:05, 2 years ago

Medicure Announces Acquisition Agreement with CanAm Bioresearch Inc.

Pharmaceuticals Intellectual Property Asset Purchase Medicure CanAm Bioresearch
BRIEF

published on 06/24/2024 at 23:05, 2 years ago

Medicure annonce un accord d'acquisition avec CanAm Bioresearch Inc.

Médicament Propriété Intellectuelle Médicaments CanAm Biorecherche Achat D'actifs
PRESS RELEASE

published on 06/24/2024 at 23:00, 2 years ago

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
Medicure Inc. announces asset purchase agreement with CanAm Bioresearch for acquisition of patent and intellectual property related to new chemical entities for therapeutic use

Medicure Inc. Asset Purchase Agreement CanAm Bioresearch New Chemical Entities Therapeutic Use

Published on 07/02/2026 at 17:50, 51 minutes ago

Fox River Completes Arrangement With Avenir Minerals Limited
Published on 07/02/2026 at 15:00, 3 hours 41 minutes ago

Storm Exploration Announces Non-Brokered Private Placement
Published on 07/02/2026 at 15:00, 3 hours 41 minutes ago

Norsemont Provides Choquelimpie Drilling Update
Published on 07/02/2026 at 14:30, 4 hours 11 minutes ago

Hillcrest Engages Market One Media Group Inc.
Published on 07/02/2026 at 13:45, 4 hours 56 minutes ago

Amarc Announces Commencement Of 2026 Aurora & Joy Copper-Gold District Drilling

View all ACCESSWIRE

Published on 07/02/2026 at 18:00, 41 minutes ago

RM plc: Holding(s) in Company
Published on 07/02/2026 at 17:40, 1 hour ago

EQS-Adhoc: Rheinmetall AG: Rheinmetall is assessing the potential impact of the cancellation of the F126 programme
Published on 07/02/2026 at 17:20, 1 hour 21 minutes ago

TIMEX GROUP TAKES FULL OWNERSHIP OF DANIEL WELLINGTON
Published on 07/02/2026 at 16:31, 2 hours 9 minutes ago

Holding(s) in Company
Published on 07/02/2026 at 16:10, 2 hours 30 minutes ago

BOOSTER Precision Components Holding announces prolongation of standstill agreement with Ad-hoc Group

View all EQS

Published on 07/02/2026 at 18:33, 7 minutes ago

Annonce des principales caractéristiques d'un projet d'offre publique de retrait et désignation expert financier
Published on 07/02/2026 at 18:28, 12 minutes ago

Emova Group - Résultats 1er semestre 2025/26
Published on 07/02/2026 at 18:00, 41 minutes ago

Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 30 juin 2026
Published on 07/02/2026 at 18:00, 41 minutes ago

Outstanding shares and voting rights statement at 30 June 2026
Published on 07/02/2026 at 17:45, 56 minutes ago

ENGIE va construire plus de 400 km de nouvelles lignes de transmission électrique au Pérou

View all LES ECHOS COMFI WIRE

News